Brought to you by:
Vascular Quality Initiative launches ‘My PAD’ pilot
The Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) has created “My PAD,” a pilot program for collecting patient-reported outcomes (PROs) from patients undergoing endovascular treatment for peripheral arterial disease (PAD). Traditional outcomes such as patency and reintervention may…
SVS publishes diversity, equity and inclusion supplement—exploring route forward
On the heels of a worldwide pandemic that has helped expose deep disparities in healthcare, the Society for Vascular Surgery (SVS) published a response—and a promise—in the form of the 2021 diversity supplement, summarizing what Society members have learned and…
FDA approves expanded PAD indication for rivaroxaban plus aspirin
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Food and Drug Administration (FDA) has approved an expanded peripheral arterial disease (PAD) indication for the Xarelto (rivaroxaban) vascular dose (2.5mg twice daily plus aspirin 100mg once daily) to…
Caring for the veteran, training the surgeon: The role of the VA in vascular surgery training
In May 1945, President Harry Truman appointed Gen. Omar Bradley to lead what is now the United States Department of Veteran Affairs, with Paul Howley, MD, as chief medical director and orthopedic surgeon Paul Magnuson, MD, as his aide.1,2 Colloquially,…
Veterans with claudication who undergo revascularization ‘significantly more likely to have major amputation than those who do not’
Patients within the Veterans Affairs Administration healthcare system who underwent an intervention for intermittent claudication (IC) were consistently at three-to-four times greater risk of undergoing subsequent amputation compared to those who did not, researchers at Stanford University report. Furthermore, Intervention…
Gore Excluder IBE ‘effectively prevented common iliac artery aneurysm enlargement’
Five-year results from the U.S. prospective, multicenter study evaluating endovascular repair of iliac aneurysms using the Gore Excluder iliac branch endoprosthesis (IBE) were presented at the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM) in San Diego Thursday morning, confirming…
Dalman: Meeting challenges of COVID-19, SVS future direction head-on
In his introduction to the second of two Presidential Addresses on the 2021 Vascular Annual Meeting (VAM) slate, new Society for Vascular Surgery (SVS) President Ali AbuRahma, MD, gave voice to that which seems virtually undeniable: that the SVS presidency…
Medical therapy linked with low early mortality in type B aortic intramural hematoma patients
Medical management of type B aortic intramural hematomas is associated with low early mortality but a 19% risk of aortic-related intervention—primarily for proximal descending thoracic aneurysms, researchers from the Mayo Clinic in Rochester, Minnesota, found. The investigators report that elevated…
Save the date for June 17, 2022, for Gala celebration
It’s our party and, unlike in the Lesley Gore classic song, there will be no crying. And there also will be far more than “16 Candles” on the cake. In fact, there’ll be 75. The celebration of the Society for…
Spotlight on Saturday’s sessions
It’s VAM’s final day and it’s a full one, with educational offerings presented from 6:30 a.m. to the meeting’s final moments at 5 p.m. Here is a rundown of what’s on offer throughout the day: 6:30 to 8 a.m. For…